跳至主要内容
临床试验/NCT03524417
NCT03524417Unknown不适用

Effect of Equine Rabies Immunoglobulin Injection on Day 7 After First Dose of Rabies Vaccination to Rabies Immune Response

Queen Saovabha Memorial Institute2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2018年4月30日最近更新:
适应症

试验速览

阶段
不适用
入组人数
20
试验地点
2
主要终点
Rabies neutralizing antibody titers

研究概览

简要总结

No study was conducted to evaluate the rabies neutralizing antibody titers after RIG injection on day 7. The only study that has supported the delay of RIG administration was done in 1996 by our institute, of which RIG was given on day 5 with the original Thai Red Cross intradermal regimen (2-2-2-0-1-1).

详细描述

Rabies immunoglobulin (RIG) should be administered as soon as possible after the initiation of post-exposure prophylaxis. RIG should not be given after day 7 following the first rabies vaccine dose, because circulating neutralizing antibody will have begun to appear. Nevertheless, no study was conducted to evaluate the rabies neutralizing antibody titers after RIG injection on day 7.

The only study that has supported the delay of RIG administration was done in 1996 by our institute, of which RIG was given on day 5 with the original Thai Red Cross intradermal regimen (2-2-2-0-1-1). The ongoing study would prove the validity of the recommendation and eliminate the controversies in clinical practice.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 - 60 years
  • WHO category III rabies exposure
  • Received rabies vaccination on day 0 and 3.

排除标准

  • Received RIG
  • Immunocompromised hosts or receiving immunosuppressive therapy
  • Received blood or blood product within 3 months
  • Received anti-malarial drugs

结局指标

主要结局

Rabies neutralizing antibody titers

时间窗: Change from baseline of geometric mean titres of rabies neutralizing antibody titres at 2 weeks

Rabies neutralizing antibody titers would be represented and compared by geometric mean titers (GMTs)

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Suda Sibunruang

Principal investigator

Queen Saovabha Memorial Institute

研究点 (2)

Loading locations...

相似试验